Laminin (Lm) a4 chain, a constituent of Lm-411 and Lm-421, is mainly localized to mesenchyme-derived tissues, and is suggested to have a role in formation and function of endothelium, transmigration of inflammatory cells through endothelium, and invasion of certain tumors. In this study, we evaluated the distribution of a4 chain Lms in 33 conventional (clear cell) renal cell carcinomas (RCCs) (31 primary tumors, two metastases), two papillary RCCs, and two oncocytomas by immunohistochemistry. In all tumors, immunoreactivity for Lm a4 chain was found in vasculature and stroma. Basement membranes were detected around tumor cell islets in 34/37 tumors. They showed immunoreactivity for Lm a4 chain in 28/34 cases. Northern blotting, inhibition of protein secretion with monensin, and immunoprecipitation combined with Western blotting showed that Caki-2, ACHN, and Caki-1 renal carcinoma cell lines produce a4 chain Lms. In cell adhesion assay, recombinant human Lm-411 did not promote adhesion of renal carcinoma cells but inhibited adhesion to fibronectin (Fn). In cell migration assay, the cells migrated more on Lm-411 than on Fn. The results suggest that a4 chain Lms have a de-adhesive function and could thus play a role in detachment, migration and invasion of renal carcinoma cells in vivo. 
Renal carcinomas account for approximately 2% of new cancer cases and 1.5% of cancer deaths globally. 1 According to the most recent classification of renal tumors, vast majority (approximately 70%) of malignant renal tumors are conventional (clear cell) renal cell carcinomas (RCCs). Other malignant tumor types are papillary RCCs, chromophobe RCCs, collecting duct carcinomas, and unclassified RCCs. Benign tumors include renal oncocytomas, papillary adenomas, and metanephric adenomas. [2] [3] [4] Carcinomas can be viewed as diseases of disrupted tissue architecture and abnormal cell-extracellular matrix interactions. Basement membranes (BMs), specialized sheets of extracellular matrix found at the epithelial-mesenchymal interface, encircling endothelia and certain types of isolated cells, seem to be critical control elements in carcinogenesis. 5, 6 In addition to maintaining tissue architecture, BMs function as selectively permeable barriers for macromolecules 7 and cells. 8 Interactions of BM constituents with cell surface receptors influence cytoskeletal organization and intracellular signaling, and thereby regulate various cell functions, including attachment, differentiation, polarization, proliferation, survival, and motility. 6, 9 The core of BM consists of independent networks of laminins (Lms) and type IV collagens bound together by nidogens. 9, 10 Developmental studies have demonstrated the essential role of Lms in BM assembly. 9 Lms are a family of at least 15 heterotrimeric, cruciform or T-shaped glycoproteins, each formed by one of the five a, three b and three g chains. 9, 11, 12 Lms, especially the Lm a chains, have developmentally regulated and tissue-specific distributions, and confer structural and functional diversity to BMs. 9 Our previous studies on RCCs have shown the presence of a1 chain Lms in stroma and BMs of tumor cell islets.
13 a3 chain-containing Lm-332 is found in papillary RCC and oncocytomas, and a5 chain Lms are widely expressed in RCCs and oncocytomas. On the other hand, a2 chain Lms are not found in renal tumors. 14 In several microarray studies comparing gene expression of renal tumors with that of normal kidneys, however, Lm a4 chain has been found to be the only Lm a chain overexpressed in renal tumors.
Lm a4 chain, a constituent of Lm-411 and Lm-421, is found in tissues of mesenchymal origin, in endothelial BMs, and in certain epithelial BMs. [19] [20] [21] It seems to promote migration and survival of endothelial cells, [22] [23] [24] migration and proliferation of blood cells, 25, 26 and transmigration of inflammatory cells through endothelium. 8 Deletion of Lm a4 chain gene in mice impairs vascular development, and leads to cardiomyopathy, demyelinating neuropathy, and increasing tumor neovascularization and metastasis. [27] [28] [29] [30] Overexpression of Lm a4 chain, on the other hand, has been suggested to promote angiogenesis, 31, 32 and to correlate with malignancy and invasive capacity in human gliomas. [33] [34] [35] [36] Tissue-specific inhibition of Lm a4 chain expression with antisense oligonucleotides has been suggested to be a potential new treatment for gliomas and tumor angiogenesis. 32, 37 The role of a4 chain Lms in carcinomas has remained largely unresolved.
38,39 Therefore, we set out to study the distribution of a4 chain Lms in RCCs and their production by RCC cells. We also evaluated the potential functional consequences of Lm a4 chain expression in RCCs by studying the effect of recombinant human Lm-411 on adhesion and migration of cultured RCC cells.
MATERIALS AND METHODS Tissues
RCCs (n ¼ 33), RCC metastases (n ¼ 2), and oncocytomas (n ¼ 2) were obtained from nephrectomies performed at the Jorvi Hospital (Espoo, Finland) and at the Oulu University Central Hospital (Oulu, Finland), frozen in liquid nitrogen, stored in À701C, and retrieved from the files of Institute of Biomedicine/Anatomy. The tumors were classified and graded by a pathologist. 14, 40 This was originally performed according to the WHO criteria. 41, 42 For the purposes of the present study, a reclassification was performed according to the Heidelberg/Rochester classification. [2] [3] [4] The tumors included 31 conventional (clear cell) RCCs (10 grade 1, 15 grade 2, and six grade 3), two metastases of conventional RCCs (one grade 1 and one grade 3), two papillary RCCs (two grade 1), and two oncocytomas.
Cultured Cells
Three RCC cell lines, Caki-2 isolated from clear cell RCC, ACHN isolated from malignant pleural effusion of patient with metastatic renal adenocarcinoma, and Caki-1 isolated from cutaneous metastasis of clear cell RCC were obtained from the American Type Culture Collection (Manassas, VA, USA). We have previously shown that, when injected subcutaneously in nude athymic mice, Caki-2 cells form well differentiated clear cell grade 1 tumors, whereas ACHN and Caki-1 cells form poorly differentiated grade 3 tumors. 43 The cells were cultured in RPMI 1640 medium (Cambrex Bioscience, Verviers, Belgium) with 10% fetal bovine serum (Perbio Science, Erembodegem, Belgium) and antibiotics.
Human dermal microvascular endothelial (HDME) cells, used as positive controls in immunoprecipitation and Western blotting, were obtained from PromoCell (Heidelberg, Germany), and cultured in Endothelial Cell Growth Medium-2 MV (EGM-2 MV; PromoCell).
Immunohistochemistry
For immunohistochemistry, we used mouse monoclonal antibodies (MAbs) 168FC10 to human Lm a4 chain, 21 114DG10 to human Lm b1 chain, 44 S5F11 to human Lm b2 chain, 45 and 113BC7 to human Lm g1 chain, 46 as well as affinity-purified rabbit antiserum to Lm a1 chain. 47 Tetramethylrhodamine isothiocyanate-coupled Ulex europaeus-I agglutinin (TRITC-UEA-I; Vector Laboratories, Burlingame, CA, USA) was used to identify blood vessel endothelia. 48 Cells grown on glass coverslips were fixed in methanol at À201C for 15 min. For inhibition of protein secretion, cells were exposed to 5 mM monensin (Sigma, St Louis, MO, USA 49 ) for 16 h before fixation. The snap-frozen tissues were cut to 6-7 mm sections and fixed in acetone at À201C for 10 min.
For light microscopy, the fixed cryosections were first exposed to MAbs, and the bound antibodies were then visualized with the alkaline phosphatase-anti-alkaline phosphatase method (APAAP mouse monoclonal, DAKO, Glostrup, Denmark), and by applying a substrate solution containing NaNO 2 (Merck, Darmstadt, Germany), New Fuchsin (Sigma), levamisole (Sigma), naphthol AS-BI phosphate (Sigma), and dimethylformamide (Merck). The sections were counterstained with Mayer's hematoxylin (Merck), mounted in Eukitt s (O Kindler, Freiburg, Germany), and examined under Olympus AX70 microscope (Olympus, Tokyo, Japan) equipped with a digital camera. For immunofluorescence microscopy, the specimens were first exposed to MAbs, followed by Alexa Fluor 488 goat anti-mouse IgG (Molecular Probes, Eugene, OR, USA). For double labeling, the specimens were then exposed either to affinity-purified rabbit antiserum to Lm a1 chain and Alexa Fluor 568 goat antirabbit IgG (Molecular Probes), or to TRITC-UEA-I. The specimens were embedded in sodium veronal-glycerol buffer (pH 8.4) or polyvinylalcohol mounting medium, and examined under a Leitz Aristoplan microscope (Leica Microsystems, Wetzlar, Germany) equipped with appropriate filters. For laser scanning confocal microscopy, a Leica TCS SP2 system (Leica Microsystems) and argon and krypton laser excitation lines 488 nm and 568 nm were used. Image stacks were collected using sequential scanning through the sections using optimized 366 nm z-sampling density. The results are shown as maximum intensity projections of four section stacks. Negative controls, in which the primary antibodies were omitted, lacked immunoreactivity.
Northern Blotting
Northern blotting was performed with digoxigenin-labeled RNA probes, using DIG Nonradioactive Nucleic Acid Labeling and Detection System by Roche (Mannheim, Germany), according to the manufacturer's instructions. A pBluescript plasmid vector (Stratagene, La Jolla, CA, USA), ). An antisense RNA probe was created first by linearizing with EcoRI (Sigma) and then introducing a digoxigenin label simultaneously with in vitro transcription, using DIG RNA Labeling kit (SP6/T7) (Roche) and T7 RNA polymerase (Roche).
Total RNA was isolated from RCC cells by using Eurozol (EuroClone, Milano, Italy), and poly(A) þ RNAs were enriched by using Dynabeads s Oligo (dT) 25 beads (Dynal, Oslo, Norway). The RNA was separated according to size on a denaturing 1.2% agarose gel and transferred onto Nylon Membranes, Positively Charged (Roche), by upward capillary transfer. Northern hybridization was performed by using DIG Easy Hyb Granules (Roche). Prehybridization was carried out at 681C for 30 min, and hybridization was carried out at 681C for 16 h. The hybridized probes were detected with antidigoxigenin-AP conjugate (Roche) and CSPD, ready-to-use (Roche). The blots were then exposed to Hyperfilm MP (Amersham Biosciences, Uppsala, Sweden). For reuse of the blots, the previously detected probes were erased by pouring boiling 0.1% sodium dodecyl sulfate (SDS) on the filter, according to the instructions by Roche. Hybridization with an antisense RNA probe to glutaraldehyde-3-phosphatedehydrogenase (GAPDH) was used as a loading control, and hybridization with a sense RNA probe to Lm a4 chain was used as a negative control (not shown). As size markers, we used RNA molecular weight marker I, digoxigenin labeled (0.3-6.9 kb) (Roche).
Immunoprecipitation and Western Blotting
For immunoprecipitation experiments, the culture media of Caki-2, ACHN, Caki-1, and HDME cells were first cleared by centrifugation, and then supplemented with Triton X-100 (0.5%) and normal mouse serum. The supernatant was preabsorbed with GammaBindt Plus Sepharoset beads (Amersham Biosciences), and subsequently applied onto GammaBindt Plus Sepharoset beads precoupled with MAb 113BC7 to Lm g1 chain. 46 The bound proteins were eluted with Laemmli's reducing sample buffer and separated by SDS polyacrylamide gel electrophoresis on 5% gels. For Western blotting the samples were transferred onto nitrocellulose filters, after which the filters were blocked using 5% dry milk in phosphate-buffered saline (PBS). The filters were subsequently exposed to rabbit antiserum to Lm a4 chain. 51 Immunoreactive bands were visualized using horseradish peroxidase-coupled anti-rabbit immunoglobulins (DAKO) with SuperSignal s West Pico Chemiluminescent Substrate (Pierce, Rockford, IL, USA), according to the manufacturers' instructions. As size markers, we used Standard Mixture for Molecular Weights 30 000-200 000 for SDS polyacrylamide gel electrophoresis (Sigma).
Cell Adhesion Assay
Quantitative cell adhesion assays were performed using a method based on intracellular acid phosphatase. 52 Recombinant human Lm-411 was produced in a mammalian expression system, as previously described. 53 Fibronectin (Fn) was purified from outdated human plasma (Finnish Red Cross Blood Transfusion Service, Helsinki, Finland) by Gelatin Sepharoset 4B affinity chromatography (Amersham Biosciences), according to Engvall and Ruoslahti. 54 Ninetysix-well plates were coated with 1-20 mg/ml recombinant human Lm-411 and/or Fn in PBS at room temperature for 1 h, washed twice with PBS, treated with 3% bovine serum albumin in PBS at room temperature for 1 h, and washed again twice with PBS. In order to avoid interference of de novo protein secretion during the experiment, cycloheximide was added (10 mg/ml; Sigma) to the culture medium of the cells 1 h before the cells were plated. 55 It was also included to washing and adhesion media. The cells were detached from the culture plates using trypsin and EDTA, exposed to a trypsin-neutralizing solution (PromoCell), and washed with the adhesion medium (RPMI 1640 without fetal bovine serum). The cells were plated at 2 Â 10 4 cells per well and incubated at 371C in 5% CO 2 for 1 h. The wells were carefully washed to remove non-adherent cells. Substrate solution (Sigma 104 phosphatase substrate 6 mg/ml in 50 mM sodium acetate buffer with 0.1% Triton X-100, pH 5) was added to each well and the plates were incubated at 371C for 1 h. The reaction was stopped with 1 M NaOH and the absorbances were measured at 405 nm. Bovine serum albumin-coated wells were used as controls. Experiments were performed in triplicate, and the absorbances were expressed 7s.d. of three wells. The difference between two variables was tested with a two-sided, unpaired t-test with a significance level of a ¼ 0.05.
Cell Migration Assay
Undirected random migration 56 of RCC cells on extracellular matrix proteins was studied by fluorescence live cell imaging (method modified from 24). First, glass bottom culture dishes (MatTek Corporation, Ashland, MA, USA) were coated with either 5 mg/ml recombinant human Lm-411 or 5 mg/ml Fn in PBS at room temperature for 1 h, washed twice with PBS, treated with 3% bovine serum albumin in PBS at room temperature for 1 h, and washed twice with PBS. The cells were labeled with 20 mM of CellTrackert Green CMFDA (Molecular Probes) for 30 min, according to the manufacturer's instructions. The cells were detached with trypsin and EDTA, exposed to a trypsin-neutralizing solution (PromoCell), washed with experiment medium (phenol red-free DMEM, Gibco, Invitrogen, Paisley, UK), and plated onto coated dishes (10 5 cells in 2 ml medium). The cells were allowed to attach at 371C in 5% CO 2 57 The experiments were performed in triplicate. Migration on each coat was expressed as average, median, and 7s.d. of total length of the migration trajectories of all cells found in all images of a microscope field (in average 65 cells/field) of a representative experiment. The difference between two variables was tested with a two-tailed Mann-Whitney U-test with a significance level of a ¼ 0.05.
RESULTS a4 Chain Lms in RCCs
First we evaluated the localization of Lm a4 chain in renal tumors by immunohistochemistry with APAAP technique and light microscopy. In oncocytomas, immunoreactivity for Lm a4 chain was found in the BM region around tumor cell islets, in capillaries (Figure 1a) , and in the region of endothelial BMs of larger blood vessels (not shown). Stromal areas between the tumor cell islets showed only traces of immunoreactivity for Lm a4 chain (Figure 1a) , whereas stromal areas around larger blood vessels showed prominent immunoreactivity (not shown).
In all RCCs representing primary tumors of grade 1-3 conventional RCCs (Figure 1b-d) , in metastases of grade 1 and 3 conventional RCCs (Figure 1e) , and in primary tumors of grade 1 papillary RCCs (Figure 1f) , immunoreactivity for Lm a4 chain was found in capillaries, in the region of endothelial BMs of larger blood vessels (not shown), and in stroma. Due to the continuous nature of the staining, the immunoreactivity of BM region around tumor cell islets could not be with certainty distinguished from the immunoreactivity of the stroma and endothelial BMs.
In order to make the separation between immunoreactivity for Lm a4 chain in BMs of endothelia, BMs of tumor cell islets, and stroma, we continued the study by double-labeling immunofluorescence microscopy. The results are summarized in Table 1 . To evaluate the presence of Lm a4 chain in BMs of tumor cell islets, we explored its colocalization with Lm a1 chain. This was based on our previous studies, which show that Lm a1 chain is typical for epithelial BMs, 58 and is also found in RCCs in BMs of tumor cell islets. 13 Linear Lm a1 chain-immunoreactive BMs were found around tumor cell islets in 2/2 oncocytomas, 10/10 grade 1, 14/15 grade 2, and 4/6 grade 3 conventional RCCs, 2/2 metastases of conventional RCCs, and 2/2 papillary RCCs. Among these tumors with Lm a1 chain-immunoreactive BMs, Lm a4 chain immunoreactivity was found in colocalization with Lm a1 chain immunoreactivity in 2/2 oncocytomas, 7/10 grade 1, 12/14 grade 2, 4/4 grade 3 conventional RCCs, 2/2 metastases of conventional RCCs, and 1/2 papillary RCCs, as exemplified by laser scanning confocal microscopy ( Figure 1g -i, metastasis of grade 3 conventional RCC, others not shown).
As further evidence for the presence of Lm a4 chain immunoreactivity in blood vessel endothelial BMs, we studied its colocalization with reactivity for endothelial marker TRITC-UEA-I. As exemplified by laser scanning confocal microscopy, immunoreactivity for Lm a4 chain was found in contact with TRITC-UEA-I-reactive endothelia in all tumors (Figure 1j-l, grade 2 conventional RCC, others not shown) .
In
14 Recently in has been suggested that there would be a shift from the expression of Lm-421 to Lm-411 during progression of malignancy in glioma and breast carcinoma. 33, 34, 38 Therefore, we re-evaluated with different MAbs the expression of Lm b1, b2, and g1 chains in a subset of our specimens, including two oncocytomas, three grade 1, three grade 2, and three grade 3 conventional RCCs, two metastases of conventional RCCs, and two papillary RCCs.
In 2/2 oncocytomas, 3/3 grade 1, 2/3 grade 2, and 3/3 grade 3 conventional RCCs, and 2/2 metastases of conventional RCCs, Lm b1, b2, and g1 chains were found in the BMs of blood vessels, the BMs of tumor cell islets, and in stroma. Lm a4 chain was present in the same locations (Figure 2a-d , metastasis of grade 3 conventional RCC, others not shown). Lm b2 chain immunoreactivity was not found in the BMs of tumor cell islets in 1/3 grade 2 conventional RCC. In this tumor, the BMs of tumor cell islets were also devoid of immunoreactivity for Lm a4 chain (not shown). In 2/2 papillary RCCs, Lm b1 and g1 chains were found in the BMs of blood vessel, stroma, and the BMs of tumor cell islets (not shown). Lm b2 chain was only found in the BMs blood vessels but not in the stroma or the Lm a1 chain-immunoreactive BMs of tumor cell islets (Figure 2e and f) . Thus, based on the localization of the constituent Lm chains, Lm a4 chain could be a constituent of both Lm-411 and Lm-421 in conventional RCCs. In papillary RCCs, constituents of Lm-411 were found in stroma and in some tumors in BMs of tumor cell islets, whereas constituents of both Lm-411 and Lm-421 were found in blood vessels.
Production of a4 Chain Lms by RCCs
The aforementioned results on the presence of Lm a4 chain in BMs of tumor cell islets suggested that Lm a4 chain could be produced by RCC cells. Therefore, we also studied its synthesis by RCC cell lines.
Northern blot analysis of RNA extracted from Caki-2, ACHN, and Caki-1 RCC cells (Figure 3) showed an Lm a4 chain transcript of approximately 6.5 kb. The expression was weakest in Caki-2 cells and strongest in Caki-1 cells.
In immunofluorescence microscopy, RCC cells grown under normal cell culture conditions showed only a weak, uniform cytoplasmic immunoreactivity for Lm a4 chain (not , and grade 1 papillary RCC (f), immunoreactivity for Lm a4 chain was found in BMs of blood vessels (long arrows) and stroma (st). The immunoreactivity of BM region around tumor cell islets (short arrows) could not be with certainty distinguished from the immunoreactivity of capillaries and stroma in most specimens. In laser scanning confocal microscopy, immunoreactivity for Lm a4 chain (g, green) and immunoreactivity for Lm a1 chain (h, red) were found in colocalization (i, yellow) in BMs of tumor cell islets (short arrows) in metastasis of grade 3 conventional RCC. Immunoreactivity for Lm a4 chain (j, green) and reactivity for TRITC-UEA-I (k, red) were found in contact (l, yellow) in endothelia of blood vessels (long arrows) in grade 2 conventional RCC. Scale bar (a-f), 50mm; (g-l), 100 mm.
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indicative of the synthesis of Lm a4 chain. After monensin treatment, Caki-1 cells showed also immunoreactivity for Lm b1 (Figure 4b ) and g1 (Figure 4c ) chains in cytoplasmic vesicles. On the other hand, negligible immunoreactivity was found for Lm b2 chain (Figure 4d ). This suggests that these cells produce Lm-411.
Immunoprecipitation of culture medium of Caki-1 and ACHN cells with MAb 113BC7 to Lm g1 chain, and Western blotting of the precipitates with rabbit antiserum to Lm a4 chain ( Figure 5 ) showed broad bands of M r 200 000-220 000, and a minor band of M r 180 000. In culture medium of Caki-2 cells (Figure 5 ), traces of proteins of M r 200 000-220 000 were detected. In previous studies, Western blotting of human Lm a4 chain has shown broad bands of M r 180 000-220 000. The variability in M r has been suggested to result from the variability of protein cleavage sites and modification of the protein by N-glycosylation and glycosaminoglycans. 26, 53, 59, 60 Figure 4 Immunoreactivity for Lm chains in Caki-1 cells after inhibition of protein secretion with monensin. Prominent immunoreactivity for Lm a4 chain (a) was found in cytoplasmic vesicles. Immunoreactivity for Lm b1 (b) and Lm g1 (c) chains was also found in cytoplasmic vesicles, whereas negligible immunoreactivity for Lm b2 chain (d) was found in the cells. Scale bar, 10 mm.
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Adhesion and Migration of RCCs on Recombinant Lm-411
Lms are known to be important in cell adhesion. 11, 61 In order to asses the role of a4 chain Lms in the adhesion of carcinoma cells, we set out to study the adhesion of Caki-2, ACHN, and Caki-1 cells to recombinant human Lm-411 and Fn by quantitative cell adhesion assay. In this assay (Figure 6 ), Caki-2, ACHN, and Caki-1 cells adhered significantly (Po0.01) to wells coated with Fn at 1 mg/ml. Maximal adhesion to Fn was achieved at 5 mg/ml coat concentration. In comparison, adhesion of RCC cells to wells coated with 1-20 mg/ml recombinant human Lm-411 was negligible. When the wells were coated with the combination of 5 mg/ml Fn and varying concentrations of Lm-411 (Figure 7) , the adhesion of Caki-1 cells to Fn was significantly (P ¼ 0.001) inhibited with 5 mg/ml Lm-411. Total inhibition of adhesion was seen with 15 mg/ml Lm-411. The adhesion of Caki-2 cells to Fn was significantly inhibited with 5 mg/ml Lm-411 (P ¼ 0.003), and 20 mg/ml Lm-411 diminished the adhesion over 90%. Adhesion of ACHN cells to Fn was significantly inhibited with 10 mg/ml Lm-411 (P ¼ 0.004), and 20 mg/ml Lm-411 reduced the adhesion over 60%.
Lms also play a role in cell migration. 21 and the distribution in RCCs, shown in the present study, it is difficult to judge whether there is overexpression The lower boundary of the box represents lower quartile, the line within the box represents median, and the upper boundary of the box represents upper quartile. Whiskers represent the lowest and highest expected observations. Marks outside the whiskers represent unexpected observations more than 1.5-fold interquartile range lower than the lower quartile or 1.5-fold interquartile range higher than the higher quartile. 70 Caki-1 (a), Caki-2 (b), and ACHN cells (c) migrated significantly (Po0.005) more on Lm-411 than on Fn.
Alpha4 chain laminins in renal cell carcinomas N Vainionpää et al at the protein level. This is due to the fact that the cell types of normal human kidney are not directly comparable to those of RCCs. Based on cytological, architectural, and immunohistochemical features it has been considered that clear cell RCCs originate from proximal tubules of nephrons. 16, 62, 63 Lm a4 chain is not found in proximal tubules of adult kidney, but it is found in the BM of evolving proximal tubules in developing kidney. 21 Thus, our observation on the presence of Lm a4 chain in RCCs in the BMs of tumor cell islets suggests a possibility that there is neo-expression of fetal characteristics in RCCs.
As to the putative overexpression, it is important to note that there was prominent expression of Lm a4 chain in the vasculature and in the stroma in all renal tumors. It is known that in many tissues a4 chain Lms are primarily produced by mesenchyme-derived cells, including endothelial cells, blood cells, smooth muscle cells, and fibroblasts. 20, 21, 26, 64 In this regard, we suspect that the overexpression of Lm a4 chain in RCC tissues, as suggested by microarray studies, [15] [16] [17] [18] is mostly due to its high expression in the vasculature and stroma in these tumors. It is noteworthy, however, that also RCC cells are capable of producing a4 chain Lms. This could reflect their assumed origin in kidney tubule epithelia, which develop from epithelial aggregates derived from condensed mesenchyme. 65 In gliomas, high expression of Lm a4 chain has been suggested to associate with increasing malignancy, tumor recurrence, and poor patient survival. 34 There was no correlation, however, between Lm a4 chain distribution and tumor grade in RCC tissues, as assessed by immunohistochemistry. In concordance, no clear correlation between Lm a4 chain expression and tumor grade has been detected in previous microarray studies of renal tumors. [15] [16] [17] [18] It has been suggested that there is a correlation between a shift from the expression of Lm-421 to the expression of Lm-411 and the progression of malignancy in gliomas and breast carcinomas. 33, 34, 38 In the present study, both Lm b1 and b2 chains were found in the BMs of tumor cell islets, stroma, and the BMs of blood vessels in conventional RCCs. In papillary RCCs, Lm b1 was found in the BMs of tumor cell islets, blood vessels, and stroma, whereas Lm b2 chain was restricted to the BMs of blood vessels. Thus, based on localization, Lm a4 chain can be in the form of both Lm-411 and Lm-421 in RCCs, and we found no correlation between Lm b chain expression and tumor grade in RCCs. Also in previous studies by Lohi et al, 14 there was no correlation between Lm b chain expression and tumor grade in RCCs.
The results on the biological functions of a4 chain Lms have thus far been inconclusive. For example, deletion of Lm a4 chain gene in mice has been suggested to both impair microvessel formation and to promote neovascularization. 27, 28 Both deletion and overexpression of Lm a4 chain gene have been suggested to promote angiogenesisrelated functions. 28, 31, 32 On the other hand, several studies have shown that a4 chain Lms are relatively poor adhesion substrata. 61, 66 They seem to promote, however, migration of endothelial cells, blood cells, and various tumor cells, 22, [24] [25] [26] 67 as well as transmigration of inflammatory cells through endothelium. 8 Our results based on a quantitative cell adhesion assay showed that recombinant human Lm-411 counteracted the adhesion of RCC cells to Fn in a concentration-dependent manner. RCC cells migrated better on Lm-411 than on Fn, which in addition to migration-promoting activity of Lm-411 could also reflect the inability of RCC cells to firmly adhere to this substratum. These results on inhibition of cell adhesion and stimulation of cell migration suggest that a4 chain Lms could have a role in tumor cell detachment and invasion. Such de-adhesive functions, which have been suggested to reflect intermediate state of adhesion, have previously been ascribed to matricellular proteins, such as tenascin-C and SPARC (secreted protein, acidic and rich in cysteine 68, 69 ). In fact, a4 chain Lms share some properties with matricellular proteins: 69 they are more abundant during development than in adult tissues, they are primarily localized to mesenchyme-derived tissues [19] [20] [21] and tumor stroma, 39 and deletion of Lm a4 chain gene in mice produces a grossly normal phenotype susceptible to injury. [27] [28] [29] [30] Furthermore, Lm a4 chain is characteristic of invasive gliomas, and inhibition of Lm a4 chain by antisense RNA seems to prevent tumor invasion and angiogenesis. 32, 35, 36 A similar characteristic has as also been described for SPARC. 69 In summary, the results of present study show that a4 chain Lms are widely expressed in oncocytomas and RCCs. They are present in the tumor vasculature, stroma, and the BMs of tumor cell islets. RCC cells themselves produce a4 chain Lms. Recombinant human Lm-411 inhibits adhesion of RCC cells to Fn, but promotes motility of RCC cells more than Fn. The results suggest that a4 chain Lms have a deadhesive function, which could have relevance in clinical behavior of these tumors.
